| Pharmaceutical Information |
| Drug Name |
Carbimazole |
| Drug ID |
BADD_D00360 |
| Description |
An imidazole antithyroid agent. Carbimazole is metabolized to methimazole, which is responsible for the antithyroid activity. |
| Indications and Usage |
For the treatment of hyperthyroidism and thyrotoxicosis. It is also used to prepare patients for thyroidectomy. |
| Marketing Status |
Not Available |
| ATC Code |
H03BB01 |
| DrugBank ID |
DB00389
|
| KEGG ID |
D07616
|
| MeSH ID |
D002231
|
| PubChem ID |
31072
|
| TTD Drug ID |
D02CKX
|
| NDC Product Code |
Not Available |
| Synonyms |
Carbimazole | Carbimazole Henning | Neo-Thyreostat | Neomercazole | Neo-Mercazole | Neo Tomizol |
|
| Chemical Information |
| Molecular Formula |
C7H10N2O2S |
| CAS Registry Number |
22232-54-8 |
| SMILES |
CCOC(=O)N1C=CN(C1=S)C |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
